Skip to content

CHU-SARI study: Role of respiratory viruses in adult hospitalizations for severe acute respiratory infections (SARI)

A descriptive observational cohort study to determine the role of respiratory viruses in adult hospitalizations for severe acute respiratory infections (SARI)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN49172439
Enrollment
250
Registered
2014-02-21
Start date
2013-11-15
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious diseases/Respiratory viruses/Epidemiology Infections and Infestations

Interventions

Screening of SARI patients at admission Nasopharyngeal swabbing Multiplex rt-PCR for respiratory viruses Collection and analysis of clinical and epidemiological data

Sponsors

Mont-Godinne Foundation (Belgium)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult (aged above 16 years) 2. New admission and within 7 days of admission 3. Fever > 38 or history of fever, cough and/or dyspnea 4. Requiring hospitalization for over 24h 5. Oral consent for nasopharyngeal swabbing

Exclusion criteria

Exclusion criteria: 1. Patients under 16 years of age 2. Patients already hospitalized and developing a SARI

Design outcomes

Primary

MeasureTime frame
1. Patients positive for at least one respiratory virus 2. Patients with risk factors All outcomes measured by prospective and retrospective review of electronic medical charts of enrolled patients (date of admission as baseline, date of discharge, and date of medical hospitalization report completed).

Secondary

MeasureTime frame
1. Viral co-infections with two or more respiratory viruses 2. Bacterial co-infections 3. Epidemiology, clinical course and outcome (risk factors, length of stay, complications, intensive care admission, death) 4. Instauration of antiviral treatment following virological diagnosis 5. Adaptation of antibiotic treatment following virological diagnosis

Countries

Belgium

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026